share_log

Chardan Capital Initiates Coverage On Omega Therapeutics With Buy Rating, Announces Price Target of $12

Chardan Capital Initiates Coverage On Omega Therapeutics With Buy Rating, Announces Price Target of $12

Chardan Capital以買入評級啓動對歐米茄療法的報道,宣佈目標股價爲12美元
Benzinga Real-time News ·  2022/09/23 05:48

Chardan Capital analyst Keay Nakae initiates coverage on Omega Therapeutics (NASDAQ:OMGA) with a Buy rating and announces Price Target of $12.

Chardan Capital分析師Keay Nakae以買入評級啓動了對歐米茄療法(納斯達克股票代碼:OMGA)的報道,並宣佈目標股價爲12美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論